8 Common Myths About Sickle Cell Disease — and What the Facts Actually Show

People often misunderstand sickle cell disease (SCD), and those misunderstandings can cause real harm. Some of the biggest sickle cell disease myths include the belief that SCD only affects Black people, that it is contagious, that people with SCD exaggerate their pain, or that sickle cell trait is the same as the disease itself.

These misconceptions about sickle cell disease contribute to stigma, delayed diagnosis, poor treatment, and discrimination. Understanding the facts can help improve care, support, and quality of life for people living with SCD.

Numerous myths about sickle cell disease persist around the world, leading to negative attitudes toward patients. As a result, many people with sickle cell disease choose to hide their diagnosis and avoid seeking medical care because they fear stigma and discrimination. Their physical and mental health may suffer as a result.

Sickle cell disease is one of the most common inherited blood disorders worldwide, affecting millions of people across multiple continents and ethnic backgrounds. The myths surrounding it are not harmless misunderstandings. This article addresses eight of the most common sickle cell myths and explains what the evidence actually shows.

Read More: Gene-Editing Therapy That Lowers Harmful Blood Fats in One Infusion: What It Means for Heart Health

Myth 1: Sickle Cell Disease Only Affects Black People

This is one of the most common and harmful misconceptions about sickle cell disease. While SCD is most common among people of African ancestry, it is not limited to any one racial or ethnic group. The disease also affects people of Hispanic, Indian, Middle Eastern, Asian, and Mediterranean backgrounds.

According to the CDC, approximately one in every 16,300 Hispanic-American births is affected by sickle cell disease. The reason SCD occurs often in some populations is linked to geography, not race. The sickle cell gene became more common in regions where malaria was widespread because people with the sickle cell trait gained partial protection against severe malaria.

Over time, migration spread the gene across continents and populations. The belief that sickle cell disease only affects Black people can lead to missed or delayed diagnoses in patients from other backgrounds.

Healthcare professionals who are unaware of the disease’s global prevalence may overlook symptoms in Hispanic, South Asian, Mediterranean, or Middle Eastern patients. Recognizing that SCD can affect people of many ethnicities helps ensure earlier diagnosis and better care.

Myth 2: Sickle Cell Disease Is Contagious

One of the oldest sickle cell disease myths is that it can spread from person to person. The reality is simple: Sickle cell disease is a genetic condition that is present at birth. It develops when a child inherits a sickle cell gene from both biological parents. SCD cannot be transmitted through physical contact, blood exposure, sexual contact, sharing food, or living in the same household.

A person cannot “catch” sickle cell disease from someone else. This sickle cell contagious myth contributes to social isolation and discrimination. Some people with SCD report being excluded or treated differently because others wrongly believe the disease can spread. Correcting this misunderstanding is essential for reducing stigma and supporting affected individuals.

Myth 3: People With Sickle Cell Are Exaggerating Their Pain

Few myths cause more immediate harm than the belief that people with SCD exaggerate their pain or seek drugs unnecessarily. Sickle cell disease is often called an invisible illness because many symptoms cannot be seen from the outside. However, one of its most serious complications is the vaso-occlusive crisis, which causes sudden and severe pain.

These pain episodes occur when sickled red blood cells block blood vessels and reduce blood flow to tissues and organs. This process is measurable and well-documented. The pain is real, severe, and caused by actual physical damage within the body.

Unfortunately, many patients encounter opioid bias in sickle cell care. Studies have found that people with SCD often wait longer for pain treatment in emergency departments compared with other patients experiencing severe pain. Research has also shown that racial and ethnic minorities frequently experience delays in receiving adequate pain management.

Myth 4: Sickle Cell Trait Is the Same as Sickle Cell Disease

Many people confuse sickle cell trait (SCT) with sickle cell disease, but they are not the same condition. Sickle cell trait occurs when a person inherits one sickle cell gene and one normal gene. As a result, they produce both hemoglobin S and normal hemoglobin A.

Most people with SCT do not experience the chronic anemia, organ damage, or painful vaso-occlusive crises associated with sickle cell disease. In everyday circumstances, they generally live healthy lives without symptoms.

Understanding the difference between the sickle cell trait and disease is important. Confusing the two can create unnecessary fear for some people while causing others to underestimate the medical needs of those living with SCD.

Myth 5: People with Sickle Cell Cannot Live Normal or Long Lives

Many people still believe that sickle cell disease is a childhood condition that prevents people from reaching adulthood. Growing up in many countries where SCD is common, some children hear that they will not survive past their teenage years. This myth can create lifelong anxiety and fear.

The reality is far more hopeful. Advances in treatment have significantly improved life expectancy for people with sickle cell disease. Medications such as hydroxyurea, preventive vaccinations, regular specialist care, and improved emergency treatment have helped many people with SCD live into their 40s, 50s, and beyond.

In addition, the gene therapy breakthrough approved by the FDA in 2023 offers potential curative options for some eligible patients. SCD remains a serious chronic condition, and life expectancy is still lower than in the general population. However, the idea that people with sickle cell disease cannot have long, productive lives is outdated and inaccurate.

Read More:  Genetic Testing for Hypertrophic Cardiomyopathy: Should Your Family Get Screened?

Myth 6: People With Sickle Cell Are Lazy

This myth is deeply damaging and completely false. One of the most common symptoms of sickle cell disease is severe fatigue. Chronic hemolytic anemia causes ongoing destruction of red blood cells, resulting in lower hemoglobin levels and reduced oxygen delivery throughout the body.

Because of this, many people with SCD experience persistent tiredness even when they appear healthy on the outside. Fatigue in SCD is not a sign of laziness, poor motivation, or lack of effort. It is a direct biological consequence of the disease.

The sickle cell laziness myth can lead to workplace discrimination, academic challenges, and unfair judgments. Employers, teachers, and colleagues may wrongly assume that a person is not trying hard enough when they are actually managing a serious medical condition.

Myth 7: People With Sickle Cell Are Immune to Malaria

This myth contains a small amount of truth, which makes it particularly misleading. Scientists believe the sickle cell gene became common in malaria-endemic regions because people with the sickle cell trait receives partial protection against severe malaria infection. However, people with sickle cell disease do not receive the same protection.

In fact, individuals with SCD may be more vulnerable to severe malaria complications because of functional asplenia, a condition in which the spleen does not work properly. This affects the body’s ability to fight certain infections.

Believing the sickle cell malaria protection myth can be dangerous. People with SCD should still follow recommended malaria prevention measures when traveling to regions where malaria is common.

Myth 8: Sickle Cell Disease Research Is Well-Funded and Well-Resourced

Many people assume that because SCD affects millions worldwide, research funding matches the disease burden. Historically, that has not been the case. Research has shown that sickle cell disease has received significantly less funding than some rarer conditions, including cystic fibrosis.

This funding gap has influenced the pace of treatment development and limited access to specialized care. For many years, treatment options for SCD remained limited despite the disease’s enormous global impact.

While the approval of gene therapies in 2023 represents a major scientific achievement, important challenges remain. Access to these treatments, healthcare equity, and continued investment in research are still pressing concerns. The sickle cell research funding gap is not simply a policy issue. It directly affects the lives of people living with the disease.

Read More: Understanding Malaria: A Comprehensive Guide to Prevention, Symptoms, and Treatment

Conclusion

Numerous myths about sickle cell disease continue to circulate worldwide, contributing to negative attitudes toward patients and causing many people to hide their diagnosis or delay seeking medical care.

Correcting these misconceptions is not simply about improving public knowledge. It directly affects access to treatment, quality pain management, workplace accommodations, and emotional well-being. Every myth challenged and corrected helps create a more informed, compassionate, and equitable future for the millions of people living with sickle cell disease.

Frequently Asked Questions

Q. Can you catch sickle cell disease from another person?

Sickle cell disease is a genetic condition inherited at birth from both biological parents. It cannot be transmitted through blood contact, sexual contact, shared environments, casual interaction, or any other form of exposure. You either inherit the gene combination that causes SCD, or you do not. Being around someone with SCD or the sickle cell trait cannot cause you to develop the disease.

Q. Is sickle cell disease the same in everyone who has it?

Sickle cell disease varies greatly from person to person. Some individuals experience relatively mild symptoms and infrequent pain crises, while others face severe complications and frequent hospitalizations. Factors such as fetal hemoglobin levels, coexisting genetic conditions, and access to treatment can all influence disease severity.

Q. Does sickle cell disease only cause pain?

Although pain crises are the most recognized symptom, SCD affects nearly every organ system. Complications can include chronic anemia, stroke, acute chest syndrome, kidney disease, eye problems, bone complications, delayed growth, and progressive organ damage.